Posted on 18 May 2015
Tags: acquisition, Endo, par
Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. Read the full story
Posted on 12 February 2015
Tags: acquisition, Actavis, asset purchase, big pharma, partnering
Actavis has entered into an agreement with Mayne Pharma, under which it will divest the U.S. rights to the Doryx Read the full story
Posted on 04 February 2015
Tags: acquisition, pharma, shanoxi
Harbin Gloria Pharma pay $380 million to acquire an 85% stake in Shanxi Powerdone, which makes chemical drugs and compound preparations. Read the full story
Posted on 06 January 2015
Tags: acquisition, big pharma, M&A, Pfizer
Pfizer has acquired a controlling interest in Redvax Read the full story
Posted on 02 December 2014
Tags: acquisition, big pharma, M&A, Otsuka
Otsuka Pharmaceutical announced an agreement with Avanir Pharmaceuticals, in which Otsuka America, acquires Avanir for USD 3.5 billion in an all-cash tender offer Read the full story
Posted on 25 November 2014
Tags: acquisition, big biotech, M&A
BioMarin Pharmaceutical and Prosensa Holding have entered into a definitive agreement in which BioMarin will offer to purchase all of the outstanding ordinary shares of Prosensa for $17.75 per share, for a total up front consideration of approximately $680 million Read the full story
Posted on 18 November 2014
Tags: Abbott, acquisition, asset purchase, big pharma, Zoetis
Zoetis announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million Read the full story
Posted on 18 November 2014
Tags: acquisition, Actavis, Allergan, big pharma, M&A
Actavis and Allergan have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock Read the full story
Posted on 07 November 2014
Tags: acquisition, M&A, perrigo
In today's m&a news, Perrigo Company announced today that it will acquire Belgium-based Omega Pharma for $4.5 billion. Read the full story